Sarcoidosis News Home | Sarcoidosis News
WEBA woman in her 50s in Florida who presented with recurrent ministrokes was eventually diagnosed with sarcoidosis only affecting the heart, called isolated cardiac sarcoidosis, a case study reports. “This case highlights the need to consider [cardiac sarcoidosis] as a potential cause of [stroke-like] events in patients with few….
First Patient Dosed in Phase 2 Trial of Namilumab - Sarcoidosis News
WEBNov 18, 2022 · Participants sought to test the experimental treatment for pulmonary sarcoidosis. The first participant has been dosed in a Phase 2 clinical trial testing the experimental therapy namilumab in people with pulmonary sarcoidosis, the therapy’s developer Kinevant Sciences announced. “We are excited to advance namilumab as a promising new ...
FDA Approves Ofev for Sarcoidosis, Other Interstistial Lung Diseases
WEBMar 16, 2020 · The FDA decision was based on positive data from this Boehringer Ingelheim-funded Phase 3 trial, in which 663 participants with progressive ILDs were treated with Ofev (150 mg twice daily) or given a placebo.. Results showed that Ofev treatment significantly slowed the decline in lung function, as measured by forced vital capacity — the average annual rate of decrease was 80.8 ml per year ...
Sarcoidosis is linked with higher risk of autoimmune disorders...
WEBJun 18, 2024 · That’s according to “ Autoimmune comorbidities associated with sarcoidosis: a case-control study in the All of Us research program,” which was published in Rheumatology Advances in Practice. The results “underscore the need for a thorough clinical history and review of systems when evaluating sarcoidosis patients, followed by appropriate screening for co-morbid autoimmune diseases as ...
What Is Sarcoidosis? – Sarcoidosis News
WEBJan 27, 2020 · Sarcoidosis is a disease marked by an over-active immune system that leads to the formation of small clumps of inflammatory cells called granulomas in different tissues and organs, affecting how well they work. Over time, granulomas can become calcified or bone-like, and cause permanent damage. Because it can affect any organ, or multiple organs at the same time, sarcoidosis takes on different ...
News Archives - Sarcoidosis News
WEBHigh blood calcium levels, or hypercalcemia, may in rare cases be a symptom of sarcoidosis, according to a case report from Morocco. Steroid medications helped ease the symptom for a man with severe hypercalcemia as a main complication of sarcoidosis of the lungs, or pulmonary sarcoidosis, according to…. …
Newly Diagnosed: Treatment Strategies for Sarcoidosis
WEBApproved Treatments. Most treatments available for sarcoidosis are used to manage symptoms and improve the quality of life for patients. They include immune-modulating therapies, anti-malarial treatments, corticosteroids, cytotoxic and cytostatic medications, immunosuppressants, and NSAIDs. Learn more.
Switch From Remicade to Newer Biosimilar Safe, Study Finds
WEBby Aisha I Abdullah PhD May 14, 2021. People with severe and difficult-to-treat sarcoidosis can safely switch from Remicade (infliximab) or its biosimilar Inflectra, to another biosimilar called Flixabi and maintain similar clinical benefits, a study reports. Six months after switching, none of these patients had stopped using Flixabi or showed ...
Cell-based Therapies for Sarcoidosis, Other Lung Conditions …
WEBApr 26, 2017 · Cell-based Therapies for Lung Conditions Including Sarcoidosis Are Safe, Analysis Concludes. by Magdalena Kegel April 26, 2017. Cell-based therapies for a variety of lung diseases can be considered safe, according to an analysis that pooled data from all available clinical trials of stem cell therapies. Although death rates were lower in ...
Sarcoidosis Treatment Options to Prednisone and Methotrexate …
WEBMar 24, 2017 · Methotrexate is also commonly prescribed to help lower the prednisone dose needed, but 20% to 40% of sarcoidosis cases do not respond to it. Also, fear of its toxicity, the need to monitor for toxic effects, and the roughly six months it takes to have an effect limits its use. Azathioprine, leflunomide, and mycophenolate mofetil (MMF) all act ...